Retatrutide Price Australia 2026 — Cost Per Vial, Per Dose & Per mg

This is part of our research peptide price breakdown series — start there for how pricing works across the whole catalogue.

Current Retatrutide Pricing by Vial Size

Retatrutide is stocked here in three vial sizes — 10mg, 20mg and 30mg — and the live price for each sits on its own product page rather than being repeated (and risking going stale) in this article:

• •Retatrutide 10mg
• •Retatrutide 20mg
• •Retatrutide 30mg

Cost Per mg: Why the 30mg Vial Isn't 3x the 10mg Price

If a 10mg vial cost $X, you'd expect a 30mg vial to cost 3×$X — but it almost never does, for Retatrutide or any other compound. A large share of what goes into a vial's price is fixed per batch rather than per milligram: synthesis setup, HPLC purification runs, third-party testing and vialling all cost roughly the same whether the batch yields 10mg vials or 30mg vials. Spreading that fixed cost over more milligrams per vial is what makes larger vials cheaper on a per-mg basis, even though the total price is higher.

The only reliable way to compare the three sizes — or to compare this listing against a competitor's — is price ÷ milligrams, not sticker price. Divide the price on each product page above by its vial size and you'll consistently see the per-mg figure drop as vial size increases. If it doesn't, that's worth a closer look rather than an assumption either way.

What Drives Retatrutide's Price Specifically

Retatrutide is a long, structurally complex peptide — publicly described in the research literature as a triple agonist acting across the GIP, GLP-1 and glucagon receptor pathways. Longer sequences require more synthesis cycles, and complex, multi-receptor-targeting peptides typically have lower synthesis yield than shorter, simpler compounds like BPC-157 or GHK-Cu. Lower yield per batch means fewer milligrams to spread the fixed costs across, which is the main reason Retatrutide sits toward the higher end of the price bands described in the pillar price guide.

None of this describes what the compound does in a research setting or implies any outcome — it's purely a synthesis-cost explanation for why the price sits where it does.

Research-Use-Only Note

Retatrutide as sold on this site is supplied strictly for in-vitro laboratory research and is not intended for human or veterinary use. This article makes no claims about outcomes, effects or dosing, and nothing here should be read as guidance for administration of any kind.

How This Compares to Other Metabolic-Research Compounds

Retatrutide sits in the same broad research category as Tirzepatide and Semaglutide — see Tirzepatide research peptide pricing for how that compound's vial pricing compares, and how Retatrutide compares to Tirzepatide and Semaglutide for the mechanistic differences between the three, separate from price.

Frequently Asked Questions

Why is the 20mg vial not exactly double the 10mg price?

Because a meaningful share of vial cost is fixed per batch (synthesis setup, testing, vialling) rather than scaling linearly with milligrams. Larger vials generally cost less per mg, not more.

Is a much cheaper Retatrutide listing ever a good sign?

Not on its own. Retatrutide's synthesis complexity puts a real floor under what a legitimate batch costs to produce — see How to Spot a Scam Peptide Supplier for what an unrealistically low price on a compound like this usually signals.

Does this article recommend a dose or vial size?

No. Vial size is a purchasing decision based on your own research protocol and budget; this article covers price mechanics only.

Disclaimer: Retatrutide is supplied for laboratory research purposes only and is not for human or veterinary use. This article contains no dosing, route or administration guidance and makes no efficacy or outcome claims. Pricing is shown live on each linked product page; nothing here should be treated as a cached or guaranteed figure.